01 Apr GLP-1 Drugs: A Breakthrough in Diabetes and Obesity Management with Emerging Regulatory Challenges Posted at 01 Apr 2026 in Current Affairs 0 Comments T h is a r ticle covers Daily Current Affairs and From GLP-1 Drugs: A Breakthrough in Diabetes and Obesity Management with Emerging Regulatory Challenges SYLLABUS MAPPING GS 3- Science & Technology- GLP-1 D rugs: A Breakthrough in Diabetes and Obesity Management with Emerging Regulatory Challenges FOR PRELIMS What are GLP-1 drugs
By binding to regional receptors in the gastrointestinal tract, GLP-1s alter gut motility in different areas of your intestines, affecting the physical contractions which push food (and waste) through your body
The meals are portioned for reduced appetite and include iron, potassium, and fiber
If fatigue persists beyond a month or worsens, it could signal other issues such as nutrient deficiencies, dehydration, or an underlying condition
Upon activation by GLP-1RA, the receptor stimulates cAMP production, which activates the PKA pathway and modulates the ERK1/2 signaling cascade
Group 1-80% claim Total THC values higher than shelf test results Group 2-20% claim Total THC values lower than shelf test results 20% of group 1 is in the 40-49% below label claims range